Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial
BackgroundReducing adverse effects during cesarean delivery and improving the quality of sensory blocks with appropriate doses of intrathecal hyperbaric bupivacaine can play an important role in the safe management of cesarean delivery. The aim of this study was to compare the doses of 10 and 12 mg...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.937963/full |
_version_ | 1828340484057071616 |
---|---|
author | Nahid Manouchehrian Farshid Rahimi-Bashar Azar Pirdehghan Fatemeh Shahmoradi |
author_facet | Nahid Manouchehrian Farshid Rahimi-Bashar Azar Pirdehghan Fatemeh Shahmoradi |
author_sort | Nahid Manouchehrian |
collection | DOAJ |
description | BackgroundReducing adverse effects during cesarean delivery and improving the quality of sensory blocks with appropriate doses of intrathecal hyperbaric bupivacaine can play an important role in the safe management of cesarean delivery. The aim of this study was to compare the doses of 10 and 12 mg of intrathecal hyperbaric bupivacaine 0.5% on sensory block level after first spinal failure in cesarean section (CS).MethodsIn this double-blind, randomized clinical trial, 40 candidates of CS after first spinal failure with class I-II based on American Society of Anesthesiologists (ASA) were randomly assigned into two equal groups (n = 20). Group A and B received the spinal anesthesia with 10 mg and 12 mg of hyperbaric bupivacaine (0.5%), respectively. Maximum levels of sensory block, motor block quality, and vital signs were measured in two groups by 60 min after SPA. Incidence of SPA complications during surgery were also recorded. Data were analyzed by SPSS ver.21 software using repeated measures analysis of variance at 95% confidence interval (CI) level.ResultsExcellent quality of sensory blocks and complete quality of motor blocks were achieved in all participants (100%). However, the mean time to onset of anesthesia (4.47 ± 0.69 vs. 3.38 ± 0.47, P < 0.001) and time to reach T10 level (60.73 ± 11.92 vs. 79.00 ± 19.21, P < 0.001) in the Group A, were significantly shorter than in the patients of Group B. The incidence of hypotension (P = 0.001), nausea/vomiting (P = 0.007) and bradycardia (P = 0.012) as well as administration of ephedrine and atropine were significantly higher in Group B compared to Group A.ConclusionSpinal anesthesia can be safely repeated with a 10 mg of hyperbaric bupivacaine 0.5% in a caesarean section after the initial spinal failure.Clinical trial registration[https://en.irct.ir/trial/40714], identifier [IRCT20120915010841N20]. |
first_indexed | 2024-04-13T22:57:11Z |
format | Article |
id | doaj.art-e7d30e24a0d746fa93abd2934204ac02 |
institution | Directory Open Access Journal |
issn | 2296-858X |
language | English |
last_indexed | 2024-04-13T22:57:11Z |
publishDate | 2022-10-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Medicine |
spelling | doaj.art-e7d30e24a0d746fa93abd2934204ac022022-12-22T02:25:58ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-10-01910.3389/fmed.2022.937963937963Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trialNahid Manouchehrian0Farshid Rahimi-Bashar1Azar Pirdehghan2Fatemeh Shahmoradi3Department of Anesthesiology, Fatemi Medical Center, Hamadan University of Medical Sciences, Hamadan, IranAnesthesia and Critical Care Department, Hamadan University of Medical Sciences, Hamadan, IranSchool of Public Health and Research Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, IranFaculty of Medical Sciences, Hamadan University of Medical Sciences, Hamedan, IranBackgroundReducing adverse effects during cesarean delivery and improving the quality of sensory blocks with appropriate doses of intrathecal hyperbaric bupivacaine can play an important role in the safe management of cesarean delivery. The aim of this study was to compare the doses of 10 and 12 mg of intrathecal hyperbaric bupivacaine 0.5% on sensory block level after first spinal failure in cesarean section (CS).MethodsIn this double-blind, randomized clinical trial, 40 candidates of CS after first spinal failure with class I-II based on American Society of Anesthesiologists (ASA) were randomly assigned into two equal groups (n = 20). Group A and B received the spinal anesthesia with 10 mg and 12 mg of hyperbaric bupivacaine (0.5%), respectively. Maximum levels of sensory block, motor block quality, and vital signs were measured in two groups by 60 min after SPA. Incidence of SPA complications during surgery were also recorded. Data were analyzed by SPSS ver.21 software using repeated measures analysis of variance at 95% confidence interval (CI) level.ResultsExcellent quality of sensory blocks and complete quality of motor blocks were achieved in all participants (100%). However, the mean time to onset of anesthesia (4.47 ± 0.69 vs. 3.38 ± 0.47, P < 0.001) and time to reach T10 level (60.73 ± 11.92 vs. 79.00 ± 19.21, P < 0.001) in the Group A, were significantly shorter than in the patients of Group B. The incidence of hypotension (P = 0.001), nausea/vomiting (P = 0.007) and bradycardia (P = 0.012) as well as administration of ephedrine and atropine were significantly higher in Group B compared to Group A.ConclusionSpinal anesthesia can be safely repeated with a 10 mg of hyperbaric bupivacaine 0.5% in a caesarean section after the initial spinal failure.Clinical trial registration[https://en.irct.ir/trial/40714], identifier [IRCT20120915010841N20].https://www.frontiersin.org/articles/10.3389/fmed.2022.937963/fullmotor blockcesarean sectionbupivacainefailed spinalspinal anesthesiasensory block |
spellingShingle | Nahid Manouchehrian Farshid Rahimi-Bashar Azar Pirdehghan Fatemeh Shahmoradi Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial Frontiers in Medicine motor block cesarean section bupivacaine failed spinal spinal anesthesia sensory block |
title | Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial |
title_full | Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial |
title_fullStr | Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial |
title_full_unstemmed | Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial |
title_short | Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial |
title_sort | comparison between 10 and 12 mg doses of intrathecal hyperbaric 0 5 bupivacaine on sensory block level after first spinal failure in cesarean section a double blind randomized clinical trial |
topic | motor block cesarean section bupivacaine failed spinal spinal anesthesia sensory block |
url | https://www.frontiersin.org/articles/10.3389/fmed.2022.937963/full |
work_keys_str_mv | AT nahidmanouchehrian comparisonbetween10and12mgdosesofintrathecalhyperbaric05bupivacaineonsensoryblocklevelafterfirstspinalfailureincesareansectionadoubleblindrandomizedclinicaltrial AT farshidrahimibashar comparisonbetween10and12mgdosesofintrathecalhyperbaric05bupivacaineonsensoryblocklevelafterfirstspinalfailureincesareansectionadoubleblindrandomizedclinicaltrial AT azarpirdehghan comparisonbetween10and12mgdosesofintrathecalhyperbaric05bupivacaineonsensoryblocklevelafterfirstspinalfailureincesareansectionadoubleblindrandomizedclinicaltrial AT fatemehshahmoradi comparisonbetween10and12mgdosesofintrathecalhyperbaric05bupivacaineonsensoryblocklevelafterfirstspinalfailureincesareansectionadoubleblindrandomizedclinicaltrial |